Truist Financial Corp Sells 5,213 Shares of SPDR S&P Biotech ETF $XBI

Truist Financial Corp decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,861 shares of the exchange traded fund’s stock after selling 5,213 shares during the quarter. Truist Financial Corp’s holdings in SPDR S&P Biotech ETF were worth $1,315,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Cerity Partners LLC boosted its stake in SPDR S&P Biotech ETF by 5.8% during the 1st quarter. Cerity Partners LLC now owns 18,605 shares of the exchange traded fund’s stock worth $1,509,000 after acquiring an additional 1,016 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 574.5% in the second quarter. Farther Finance Advisors LLC now owns 7,082 shares of the exchange traded fund’s stock valued at $587,000 after buying an additional 6,032 shares in the last quarter. N.E.W. Advisory Services LLC bought a new position in SPDR S&P Biotech ETF in the first quarter valued at approximately $95,000. Investment Partners Asset Management Inc. lifted its stake in SPDR S&P Biotech ETF by 4.0% in the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after buying an additional 125 shares in the last quarter. Finally, Meridian Investment Counsel Inc. lifted its stake in SPDR S&P Biotech ETF by 3.7% in the second quarter. Meridian Investment Counsel Inc. now owns 13,206 shares of the exchange traded fund’s stock valued at $1,095,000 after buying an additional 470 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $104.99 on Monday. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $107.26. The firm’s 50 day moving average price is $93.98 and its two-hundred day moving average price is $85.77. The firm has a market cap of $6.21 billion, a P/E ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.